Clinical Trials Directory

Trials / Completed

CompletedNCT01125722

Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB)

Pilot Clinical Trial to Study the Effectiveness of a Four-week Exposure to a Transcutaneous, High-frequency, Amplitude-modulated, Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence in Subjects With Idiopathic Overactive Bladder (OAB)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
Ethicon Endo-Surgery · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the non-invasive neurostimulation patch is effective in the treatment of urgency, frequency and urge (urinary) incontinence.

Detailed description

While the precise cause of OAB symptoms (urge, frequency, incontinence) is not clear, most physicians and researchers accept the theory that a problem in the communication between the central nervous system and the bladder is a factor. Research has shown that a process called neuromodulation of the nerves controlling the bladder can overcome this communication problem. In patients who have symptoms caused by the communication problem, neuromodulation has been clinically proven to eliminate or significantly reduce those symptoms. While neuromodulation has been previously achieved by implanting an electrode near the sacral nerve in the spine, the new concept under investigation within this protocol is believed to achieve a similar effect from adhesive electrodes placed on the skin over spinal nerves in the lower back.

Conditions

Interventions

TypeNameDescription
DEVICENon-invasive neurostimulation deviceActive electrode patches are worn for 4 weeks, one per week, during the treatment phase of the study. The patch is placed by the investigator.
DEVICENon-invasive neurostimulation deviceActive electrode patches are worn for 4 weeks, one per week, during the treatment phase of the study. The patch is placed by the subject.

Timeline

Start date
2010-04-01
Primary completion
2011-02-01
Completion
2011-03-01
First posted
2010-05-18
Last updated
2012-12-17
Results posted
2012-12-17

Locations

11 sites across 3 countries: United States, Sweden, United Kingdom

Source: ClinicalTrials.gov record NCT01125722. Inclusion in this directory is not an endorsement.